Showing results (121-130 of 1,124) with videos related to
Sort By:
Pageof 113
International Journal of Mycobacteriology|January 4, 2017
Cloning, expression, and purification of recombinant protein MPT-64 from a virulent strain of Mycobacterium bovis in a prokaryotic systemMaryam Mohammadi Tashakkori, Majid Tebianian, Mohammad Tabatabaei, et al.International Journal of Mycobacteriology|January 4, 2017
New approaches in drug treatment for tuberculosis: Inhalation using liposomes only a future vision or soon in clinical practice?Lars-Olof LarssonInternational Journal of Mycobacteriology|January 4, 2017
Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in ChinaYi Hu, Xubin Zheng, Zhu Ning, et al.International Journal of Mycobacteriology|January 4, 2017
Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, AngolaJoão Perdigão, Sofia Clemente, Jorge Ramos, et al.International Journal of Mycobacteriology|January 4, 2017
Screening new tuberculosis patients in Mali for rifampicin resistance at 2monthsBassirou Diarra, Aissata B Cissé, Ousmane Kodio, et al.International Journal of Mycobacteriology|January 4, 2017
Thoracic surgical interventions for DR-TB and their resultsRavindra Kumar DewanInternational Journal of Mycobacteriology|January 4, 2017
Implementation of new tools for multidrug-resistant tuberculosis detection and controlRobin M WarrenInternational Journal of Mycobacteriology|January 4, 2017
Importance of the α10 helix for DevR activation: A road map for screening inhibitors against DevR-mediated dormancy of Mycobacterium tuberculosisAtul Vashist, D Prithvi Raj, Umesh Datta Gupta, et al.International Journal of Mycobacteriology|January 4, 2017
Activity of drugs against dormant Mycobacterium tuberculosisA Iacobino, G Piccaro, F Giannoni, et al.International Journal of Mycobacteriology|January 4, 2017
Identification of novel Mycobacterium tuberculosis dihydrofolate reductase inhibitors through rational drug designMymoona AkhterPageof 113